From Concept through Commercialization: Osmotica Meets Patient Needs


We sell a diverse portfolio consisting of five promoted products and approximately 35 non-promoted products, several of which incorporate our proprietary Osmodex® drug delivery system. Our non-promoted product portfolio includes methylphenidate HCl ER tablets and venlafaxine HCl ER tablets and prescription and non-prescription dietary supplements.

We invite you to review the product websites and full prescribing information for more information.

Methylphenidate HCl ER 72 mg Tablets (M-72)

Lorzone® (chlorzoxazone USP) Tablet

prescribing information

ConZip® (tramadol hydrochloride) Extended-Release Capsules

prescribing information

Divigel® (estradiol gel) 0.1%

OB Complete®

Drug Safety

Patient safety is our highest priority, and it is our responsibility to monitor the safety of the products we develop. If you are a patient experiencing a potential adverse event or if you have questions about your condition, please contact your health care practitioner. To report an adverse event or a product complaint about our products, please contact us at:

Phone: 1-877-482-3788 or the FDA by visiting or calling 1-800-FDA-1088.

For additional information about our products, please visit and